Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (391-400 of 599) with videos related to

Pageof 60
Sort By:
Journal of Medicinal Chemistry|September 23, 2022
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2<i>H</i>-naphtho[1,2-<i>b</i>][1,4]diazepine-2,4(3<i>H</i>)-diones as P2X4 Receptor AntagonistsKiran S Toti, Rajkumar Verma, Michael J McGonnigle, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo EfficacyDilip K Tosh, Steven Crane, Zhoumou Chen, et al.
International Journal of Molecular Sciences|August 7, 2021
Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A<sub>3</sub> Receptor SubtypeElisabetta Coppi, Federica Cherchi, Elena Lucarini, et al.
Pharmacological Research|June 22, 2021
Optical control of adenosine A<sub>3</sub> receptor function in psoriasisMarc López-Cano, Ingrid Filgaira, Ernest G Nolen, et al.
Scientific Reports|July 18, 2018
Activation of basal forebrain purinergic P2 receptors promotes wakefulness in miceChun Yang, Andrei Larin, James T McKenna, et al.
Journal of Medicinal Chemistry|April 10, 2014
4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptorsP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Purinergic Signalling|July 29, 2020
Design and in vivo activity of A<sub>3</sub> adenosine receptor agonist prodrugsR Rama Suresh, Shanu Jain, Zhoumou Chen, et al.
The Journal of Biological Chemistry|May 5, 2005
Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptorSung-Jun Han, Fadi F Hamdan, Soo-Kyung Kim, et al.
Neurochemistry International|April 27, 2013
Dopamine D(2) receptor-mediated modulation of adenosine A(2A) receptor agonist binding within the A(2A)R/D(2)R oligomer frameworkVíctor Fernández-Dueñas, Maricel Gómez-Soler, Xavier Morató, et al.
Journal of Medicinal Chemistry|December 22, 2005
Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preferenceStefano Costanzi, Bhalchandra V Joshi, Savitri Maddileti, et al.
Pageof 60

Showing results (391-400 of 599) with videos related to

Sort By:
Pageof 60
Journal of Medicinal Chemistry|September 23, 2022
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2<i>H</i>-naphtho[1,2-<i>b</i>][1,4]diazepine-2,4(3<i>H</i>)-diones as P2X4 Receptor AntagonistsKiran S Toti, Rajkumar Verma, Michael J McGonnigle, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Rigidified A3 Adenosine Receptor Agonists: 1-Deazaadenine Modification Maintains High in Vivo EfficacyDilip K Tosh, Steven Crane, Zhoumou Chen, et al.
International Journal of Molecular Sciences|August 7, 2021
Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A<sub>3</sub> Receptor SubtypeElisabetta Coppi, Federica Cherchi, Elena Lucarini, et al.
Pharmacological Research|June 22, 2021
Optical control of adenosine A<sub>3</sub> receptor function in psoriasisMarc López-Cano, Ingrid Filgaira, Ernest G Nolen, et al.
Scientific Reports|July 18, 2018
Activation of basal forebrain purinergic P2 receptors promotes wakefulness in miceChun Yang, Andrei Larin, James T McKenna, et al.
Journal of Medicinal Chemistry|April 10, 2014
4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptorsP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Purinergic Signalling|July 29, 2020
Design and in vivo activity of A<sub>3</sub> adenosine receptor agonist prodrugsR Rama Suresh, Shanu Jain, Zhoumou Chen, et al.
The Journal of Biological Chemistry|May 5, 2005
Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptorSung-Jun Han, Fadi F Hamdan, Soo-Kyung Kim, et al.
Neurochemistry International|April 27, 2013
Dopamine D(2) receptor-mediated modulation of adenosine A(2A) receptor agonist binding within the A(2A)R/D(2)R oligomer frameworkVíctor Fernández-Dueñas, Maricel Gómez-Soler, Xavier Morató, et al.
Journal of Medicinal Chemistry|December 22, 2005
Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preferenceStefano Costanzi, Bhalchandra V Joshi, Savitri Maddileti, et al.
Pageof 60